GlassScriptPhysician profile
Richard J Helton
NPI 1497196687
$1,676.29
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $947 · 2020: $248 · 2021: $311 · 2022: $145 · 2023: $24.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $461.29 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $259.47 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $191.98 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.79 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $70.86 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $60.08 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $55.31 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.66 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $46.73 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $42.59 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $35.80 | 2019 | |
| Mylan Specialty L.P. | $31.29 | 2019 | |
| United Therapeutics Corporation | $27.17 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $26.17 | 2019 | |
| Alexion Pharmaceuticals, INC. | $25.83 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $24.94 | 2023 | Irrisept |
| Sanofi-Aventis U.S. LLC | $22.42 | 2021 | |
| Gilead Sciences, INC. | $21.47 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20.12 | 2019 | |
| Chiesi USA, INC. | $19.35 | 2019 | |
| Paratek Pharmaceuticals, INC. | $18.27 | 2019 | |
| Edwards Lifesciences Corporation | $18.22 | 2019 | |
| Mannkind Corporation | $17.09 | 2021 | |
| Insmed, INC. | $15.15 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Helton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.